Trials / Withdrawn
WithdrawnNCT01982318
A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
A Prospective, Multi-Center, Randomized, Double Blind, Placebo-Controlled Trial Comparing Vitrogro® ECM To Placebo As An Adjunct To Standard Care In Patients With Venous Leg Ulcers
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Tissue Therapies Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VitroGro® ECM | |
| DRUG | Dulbecco's Phosphate Buffered Saline |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-06-01
- Completion
- 2019-06-01
- First posted
- 2013-11-13
- Last updated
- 2017-05-30
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01982318. Inclusion in this directory is not an endorsement.